Sanofi: Q2 2018 Performance Positions Sanofi for New Growth Phase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Sanofi (SNY) Tops Q2 EPS by 5c
July 31, 2018 8:11 AM EDTSanofi (NYSE: SNY) reported Q2 EPS of EUR1.25, EUR0.05 better than the analyst estimate of EUR1.20. Revenue for the quarter came in at EUR8.18 billion versus the consensus estimate of EUR8.36 billion.
For earnings history and earnings-related data on Sanofi (SNY) click here.
... More